University of Dundee, MSc Human Clinical Embryology and Assisted Conception - Apply now for September 2018
Page URL: https://www.bionews.org.uk/page_92510

New genetic markers linked to breast cancer risk

9 August 2010
Appeared in BioNews 570

A large prospective study has discovered new genetic variants associated with an increased risk of breast cancer.

The scientists from Oxford University in the UK compared data from over 10,000 women with breast cancer and 10,000 women without the disease. 

They analysed 14 SNPs (single nucleotide polymorphisms) alone and in combination that were previously associated with breast cancer, to see how they related to risk and cancer subtype.

The researchers also performed a meta-analysis on the data from this study and other related studies.

They found that SNPs in the FGFR1 and TNRC9 genes, as well as a third SNP on Chromosome 2, were associated with an overall increase in risk, and that prediction was most reliable for oestrogen receptor (ER) positive cancers and lower grade tumours.

The study concluded that women under 70 years of age with the highest polygenic risk scores had double the breast cancer risk of 8.8 per cent compared to 4.4 per cent in women with the lowest polygenic scores.

The PHG Foundation commenting on this research said: ‘This is an important study which evaluates the predictive value of selected genetic markers identified by different studies and finds that it varies for different tumour subtypes’.

‘Ultimately the combination of established and novel environmental and genetic risk factors could refine risk prediction for targeted population screening’.

The research is published in JAMA.

SOURCES & REFERENCES
Genetic factors in breast cancer risk prediction
PHG Foundation |  5 August 2010
Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci
JAMA |  28 July 2010
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
16 May 2011 - by Dr Kimberley Bryon-Dodd 
Screening for breast and prostate cancer based on genetic risk factors as well as age could reduce the number of people screened without a significant reduction in the number of cancers detected, a new study suggests....
28 February 2011 - by Sarah Pritchard 
Scientists in the UK and Canada have discovered a new oncogene - the genes responsible for cell multiplication - that plays a role in the development of a particularly aggressive form of breast cancer....
1 November 2010 - by Rosemary Paxman 
An embyro screening test could significantly increase IVF success rates, US researchers have found...
13 September 2010 - by Chris Chatterton and Jay Stone 
A group of international researchers have become the first to link the cumulative effects of single nucleotide polymorphisms (SNP) in genes responsible for the production of oestrogen, to a woman's risk of developing common breast and uterine cancers....
14 June 2010 - by MacKenna Roberts 
The Australian Federal Court in Sydney is considering groundbreaking legal action of whether private companies can obtain patents on human genes....
7 June 2010 - by Dr Tamara Hirsch 
Women who inherit genes linked to breast cancer have no greater risk than other women of developing the disease as a result of lifestyle choices, including hormone replacement therapy (HRT) and alcohol consumption, according to a recent study in The Lancet....
26 April 2010 - by Dr Lux Fatimathas 
Rats fed on high-fat diets increased the chances of their daughters and granddaughters developing breast cancer, a US study has found...
18 October 2009 - by Rosie Beauchamp 
A research team led by Professor Gareth Evans at theNightingale Centre and Genesis Prevention Centre based in the Wythenshawe Hospital in Greater Manchester, UK, will carry out the biggest ever study to look at the causes of breast cancer with the aim of improving screening and diagnosis. One in 10 women in the UK develop breast cancer with 44,000 diagnoses a year, making it the most common cancer in British women....
29 June 2009 - by Dr Rebecca Robey 
A new drug for the treatment of inherited forms of breast, ovarian and prostate cancer has shown promising results in early clinical trials. The study, published in the New England Journal of Medicine, reported that the drug promoted tumour reduction and clinical improvement in advanced-stage cancer patients whilst causing fewer side effects than conventional chemotherapy....
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.